BNOX יחס מהיר Bionomics Ltd.

Bionomics Limited focuses on expanding its BNC210 small molecule portfolio to combat anxiety, utilizing advanced chemical engineering for targeted brain receptor action without the risk of addiction. This daily price chart reflects the current 3.22 coefficient. Meanwhile, the systematic expenditure on research is offset by partner support, preventing a critical liquidity shortage.

For the biotechnology business Bionomics Limited (BNOX), the quick ratio serves as an indicator of survivability amidst the heavy costs of clinical phases. This metric determines the company's ability to settle short-term obligations, excluding illiquid inventories from the calculation. The formula accounts exclusively for cash and accounts receivable. A stable level of this indicator confirms financial stability in the absence of operating profit and the stagnation of current revenues.